Vector for integration site independent gene expression in mammalian host cells
CA 2297385 A1 · Owner: Celltech Limited · Inventors: Eccles, Sarah J.; Grosveld, Franklin Gerardus
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides a transgenic mammal transformed with a vector, the vector comprising a promoter and a gene to be expressed, wherein the vector includes an immunoglobulin dominant control region capable of eliciting host cell-type restricted, integration site independent copy number, dependent expression of the said gene.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 22, 1990. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 22, 2010.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 22, 2012.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.